Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Francisco Girón Fernández-Crehuet"'
Autor:
Javier Blasco-Alonso, Cristina Yun-Castilla, Francisco Girón-Fernández-Crehuet, Mª José Peláez-Cantero, Juliana Serrano-Nieto, Víctor Manuel Navas-López, Carlos Sierra-Salinas
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 106, Iss 3, Pp 159-164 (2014)
Introduction: The conventional 24-hour pH monitoring is the gold standard for the diagnosis of gastro-esophageal reflux (GER), a possible cause of Apparent Life Threatening Episodes (ALTE). However, multichannel intraluminal impedance (MII) may provi
Externí odkaz:
https://doaj.org/article/88b9c9ebf9e742be9c2e6b13c05714cd
Autor:
Víctor Manuel Navas-López, Javier Blasco-Alonso, Francisco Girón-Fernández-Crehuet, María Juliana Serrano-Nieto, Carlos Sierra-Salinas
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 105, Iss 10, Pp 579-584 (2013)
Objectives: to describe the efficacy and safety of adalimumab (ADA) in inducing clinical remission and reducing inflammation of intestinal mucosa in children with Crohn's disease (CD). Methods: we carried out a descriptive, observational study with a
Externí odkaz:
https://doaj.org/article/b83475ff4571478f8c7cebe502bfad26
Autor:
Francisco Girón Fernández-Crehuet, Michal Kolorz, Silvia Luque-Pérez, Víctor Manuel Navas-López, Katerina Lukac, Paloma García-Galán, Ladislava Bartošová, Silvia Gallego-Gutiérrez, María Juliana Serrano-Nieto, Carlos Sierra-Salinas, Leticia Núñez-Caro, Javier Blasco-Alonso
Publikováno v:
Journal of Crohn's and Colitis. 9:676-679
Background: Azathioprine [AZA] and mercaptopurine [MP] are recommended for maintenance of steroid-free remission in children with Crohn`s disease [CD]. Azathioprine-induced pancreatitis, an idiosyncratic and major side effect, has been considered as
Autor:
María Juliana Serrano Nieto, Silvia Luque Pérez, Carlos Sierra Salinas, Víctor Manuel Navas-López, Francisco Girón Fernández-Crehuet, Javier Blasco-Alonso, Silvia Gallego-Gutiérrez
Publikováno v:
Clinical Journal of Gastroenterology. 7:320-323
Ulcerative colitis (UC) is defined as a chronic inflammatory condition causing continuous mucosal inflammation of the colon without granulomas on biopsy. It affects the rectum, and, to a variable extent, the colon in continuity and is characterized b
Autor:
Juliana Serrano Nieto, Javier Blasco Alonso, Victor Lopez, Silvia Luque Pérez, Francisco Girón Fernández-Crehuet, Sivia Gallego Gutiérrez, Carlos Sierra Salinas, Miguel Angel Lendinez Ramirez
Publikováno v:
Revista Española de Enfermedades Digestivas v.108 n.9 2016
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Revista Espanola de Enfermedades Digestivas, Vol 108, Iss 9, Pp 598-603
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Revista Espanola de Enfermedades Digestivas, Vol 108, Iss 9, Pp 598-603
Introduction and objectives Metastatic Crohn's disease (MCD) is an extraintestinal manifestation of Crohn's disease, with biopsy as fundamental diagnostic tool. There are few references to MCD in children, with a 0.5-1% estimated incidence in adults.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::334cf1d985f82a70334e0ca2fc8a27e9
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082016000900019
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082016000900019
Autor:
Javier Blasco-Alonso, Francisco Girón-Fernández-Crehuet, Miguel Ángel Lendinez-Ramírez, Silvia Gallego-Gutiérrez, Silvia Luque Pérez, Juliana Serrano-Nieto, Víctor M. Navas-López, Carlos Sierra-Salinas
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 108, Iss 9, Pp 598-603
Introduction: Metastatic Crohn's disease (MCD) is an extraintestinal manifestation of Crohn's disease, with biopsy as fundamental diagnostic tool. There are few References to MCD in children, with a 0.5-1% estimated incidence in adults. There is no c
Externí odkaz:
https://doaj.org/article/a070b93e1e7f4f678fca0d0e238fbdd1
Autor:
Javier Blasco-Alonso, Carlos Sierra-Salinas, María Juliana Serrano-Nieto, Víctor Manuel Navas-López, Francisco Girón-Fernández-Crehuet
Publikováno v:
Revista Española de Enfermedades Digestivas v.105 n.10 2013
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Revista Espanola de Enfermedades Digestivas, Vol 105, Iss 10, Pp 579-584 (2013)
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Revista Espanola de Enfermedades Digestivas, Vol 105, Iss 10, Pp 579-584 (2013)
Objectives: to describe the efficacy and safety of adalimumab (ADA) in inducing clinical remission and reducing inflammation of intestinal mucosa in children with Crohn's disease (CD). Methods: we carried out a descriptive, observational study with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8c768ea8e9ba72b5dccb6d129069a47
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082013001000002
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082013001000002